The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 11, 2018
Filed:
Mar. 24, 2016
Applicant:
Tetraphase Pharmaceuticals, Inc., Watertown, MA (US);
Inventors:
Chi-Li Chen, Watertown, MA (US);
Roger B. Clark, Lexington, MA (US);
Yonghong Deng, Watertown, MA (US);
Minsheng He, Watertown, MA (US);
Louis Plamondon, Montreal, CA;
Cuixiang Sun, Watertown, MA (US);
Xiao-Yi Xiao, Lexington, MA (US);
Magnus P. Ronn, Melrose, MA (US);
Assignee:
Tetraphase Pharmaceuticals, Inc., Watertown, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/65 (2006.01); C07C 237/26 (2006.01); C07D 471/10 (2006.01); C07C 275/24 (2006.01); C07C 311/06 (2006.01); C07C 311/19 (2006.01); C07D 205/04 (2006.01); C07D 207/06 (2006.01); C07D 207/08 (2006.01); C07D 207/10 (2006.01); C07D 209/04 (2006.01); C07D 209/44 (2006.01); C07D 211/14 (2006.01); C07D 211/34 (2006.01); C07D 213/74 (2006.01); C07D 221/20 (2006.01); C07D 223/04 (2006.01); C07D 223/32 (2006.01); C07D 295/13 (2006.01); C07D 295/15 (2006.01); C07D 295/155 (2006.01); C07D 207/09 (2006.01); C07D 207/14 (2006.01); C07D 207/16 (2006.01); C07D 209/14 (2006.01); C07D 209/52 (2006.01); C07D 223/14 (2006.01); C07D 261/20 (2006.01); C07D 295/135 (2006.01); C07D 295/185 (2006.01); C07D 295/26 (2006.01); C07D 307/22 (2006.01); C07D 401/04 (2006.01); C07D 413/06 (2006.01);
U.S. Cl.
CPC ...
C07D 471/10 (2013.01); C07C 237/26 (2013.01); C07C 275/24 (2013.01); C07C 311/06 (2013.01); C07C 311/19 (2013.01); C07D 205/04 (2013.01); C07D 207/06 (2013.01); C07D 207/08 (2013.01); C07D 207/09 (2013.01); C07D 207/10 (2013.01); C07D 207/14 (2013.01); C07D 207/16 (2013.01); C07D 209/04 (2013.01); C07D 209/14 (2013.01); C07D 209/44 (2013.01); C07D 209/52 (2013.01); C07D 211/14 (2013.01); C07D 211/34 (2013.01); C07D 213/74 (2013.01); C07D 221/20 (2013.01); C07D 223/04 (2013.01); C07D 223/14 (2013.01); C07D 223/32 (2013.01); C07D 261/20 (2013.01); C07D 295/13 (2013.01); C07D 295/135 (2013.01); C07D 295/15 (2013.01); C07D 295/155 (2013.01); C07D 295/185 (2013.01); C07D 295/26 (2013.01); C07D 307/22 (2013.01); C07D 401/04 (2013.01); C07D 413/06 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05); C07C 2601/18 (2017.05); C07C 2602/08 (2017.05); C07C 2602/24 (2017.05); C07C 2602/42 (2017.05); C07C 2602/50 (2017.05); C07C 2603/46 (2017.05); C07C 2603/74 (2017.05);
Abstract
The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.